• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

Cowboy's Profile

Avatar:

Membership:

Premium

Person Marks:

9

Total Posts:

99

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

3

Alias Born

05/28/2012 7:40:46 PM

Personal info

Recent Articles

• Republic of Chile to Offer Euro Notes and Exchange Opportunities
• Investors Can Join Class Action Against Napco Technologies
• ZetaDisplay AB Announces Changes in Board of Directors
• KH Group's Saurus Oy Secures Major Order for Defence Vehicles
• Nykredit Realkredit A/S Drawings Update for Investors
• Pandora's Comprehensive Share Buyback Program Insights
• Understanding Riksbank Certificates: Key Sale Conditions Explained
• Transformative Changes at Davis Commodities Limited Unveiled
• Monster Energy Dominates Action Sports at X Games Osaka 2025
• Breye Therapeutics Advances Danegaptide in Diabetic Eye Disease
• EQT Divests Recover: A New Chapter in Property Remediation
• Details on Harboes Bryggeri A/S Annual General Meeting
• Strengthening Ties: The New Era of China-Central Asia Relations
• Innovative Partnership between Dolby and Audi Revolutionizes Sound
• Dstny Group Welcomes Pieter Verstraeten as New CRO for Growth
• MemorialCare Hospitals Set New Standards for Neurodiagnostics
• ANBC Leads Dialogue on AI and Credit at International Conference
• Community Policing: Zephyrhills Police Department Shines
• Dstny Group Welcomes Pieter Verstraeten as New CRO
• Discover the Health Benefits of Arkay's Zero Proof Spirits
• Innovative AI Platform Launched to Enhance Waste Management
• Strengthening Media Ties: The China-Central Asia Forum
• Transformative Insights from the June 2025 Ericsson Report
• Unlock Potential with AAS Miner for Cloud Crypto Mining Income
• BlackRock Inc. Notifies Syensqo on Shareholding Changes
• Lundbeck's Breakthrough Drug Designation for CAH Treatment
• Lundbeck's Lu AG13909 Receives Orphan Drug Designation
• Empowering Youth for Global Peace: 2025 Prize Submissions Open
• Key Insights on 5G Fixed Wireless Access Monetization Growth
• Equinor ASA's Strategic Share Buy-Back Program Unveiled
• Foresight Group's Strategic Share Buyback Milestone Achieved
• EXACT Therapeutics Doses First Patient in Pivotal Cancer Trial
• Exciting Insights on NB Private Equity Partners' Recent Share Buy-Back
• Volvo Construction Equipment's Strategic Acquisition of Swecon
• Volvo CE Completes Strategic Shift by Divesting SDLG Stake
• Implantica Advances RefluxStop® Approval with FDA Submission
• AISWEI's Display of Innovation at the Global Clean Energy Event
• Navamedic ASA Announces Strategic Acquisition of DNE Pharma
• Unlocking a New Era of Security: Fuse Identities' Innovation
• ICG Enterprise Trust Updates Share Buyback Strategy
• Renault Group Announces Strategic Share Buyback Initiative
• ING Group Updates on Their Strategic Share Buyback Program
• Pulsar Helium Partners with Sproule-ERCE for Tunu Project Study
• Norsk Hydro Q2 2025 Insights: Earnings, Webinar, and More
• Diversified Energy Forms Partnership with Carlyle for $2 Billion Investment
• DeepL Expands Language Offerings to Boost Global Communication
• ANA and Trip.com Enhance Global Ticket Sales with NDC
• Nippon Shokubai Expands Production of Nucleic Acid Drugs
• DeepL Expands Language Offerings to Enhance Global Business Reach
• The Vital Role of Hand Hygiene in Saving Millions of Lives